Rafferty Asset Management’s Cue Biopharma CUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-97,062
| Closed | -$1.1M | – | 1239 |
|
|
2021
Q4 | $1.1M | Buy |
97,062
+58,054
| +149% | +$657K | 0.01% | 828 |
|
|
2021
Q3 | $568K | Sell |
39,008
-13,544
| -26% | -$197K | ﹤0.01% | 1017 |
|
|
2021
Q2 | $612K | Sell |
52,552
-6,806
| -11% | -$79.3K | ﹤0.01% | 1031 |
|
|
2021
Q1 | $724K | Buy |
59,358
+46,202
| +351% | +$564K | ﹤0.01% | 864 |
|
|
2020
Q4 | $165K | Sell |
13,156
-20,256
| -61% | -$254K | ﹤0.01% | 998 |
|
|
2020
Q3 | $503K | Buy |
33,412
+24,460
| +273% | +$368K | 0.01% | 696 |
|
|
2020
Q2 | $219K | Buy |
+8,952
| New | +$219K | ﹤0.01% | 907 |
|